Indication for LOVENOX
®
(enoxaparin sodium injection)
LOVENOX
®
can help reduce the risk of developing deep vein thrombosis (DVT) blood clots, which may lead to pulmonary embolism (PE), in
patients undergoing abdominal surgery, hip- or knee-replacement surgery, or in acutely ill medical patients with severely restricted mobility.
Important Safety Information for LOVENOX
®
If you are receiving epidural or spinal anesthesia or undergoing spinal puncture, and taking LOVENOX
®
(enoxaparin sodium injection),
you may be at increased risk of developing a blood clot in or around the spine, which can result in long-term paralysis. Your risk may be
further increased if you:
• Take nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, or other anticoagulants, such as aspirin or blood thinners
• Have an indwelling epidural catheter
• Have a history of spinal trauma, or repeated spinal anesthesia or punctures
• Have a history of spinal deformities or spinal surgery
It is important to contact your doctor immediately if you experience symptoms such as tingling, numbness (especially in the lower limbs),
or muscular weakness.
LOVENOX
®
should not be used in patients who are actively bleeding or who have a low count of blood cells called platelets, which aid
in clotting. This is a condition called “thrombocytopenia.” LOVENOX
®
also should not be used in patients who are allergic or sensitive to
LOVENOX
®
or enoxaparin, heparin, or pork products.
LOVENOX
®
must be used with care in patients who have any of the following: problems with clotting, uncontrolled high blood pressure, a
recent ulcer, impaired vision due to diabetes, kidney problems, and excessive bleeding. Pregnant women with mechanical prosthetic (artificial)
heart valves may be at higher risk for blood clots. These patients who are treated with LOVENOX
®
must be carefully monitored by their doctor.
Some patients on LOVENOX
®
can experience drops in their platelet counts, a condition called “thrombocytopenia.” Also, a serious but rare
condition called “heparin-induced thrombocytopenia” can occur with LOVENOX
®
. If you have had this condition, you must promptly notify
your healthcare professional.
LOVENOX
®
alters the blood’s ability to clot. Excessive bleeding (hemorrhage), leading to death, has occurred with LOVENOX
®
. Bleeding can
occur at any site with LOVENOX
®
use. The use of aspirin and other NSAIDs may enhance the risk of excessive bleeding. Be sure to tell all your
doctors and dentist about all of the medications you are taking, including those you are taking without a prescription, such as aspirin or other
NSAIDs. Also be sure to tell your doctor or dentist you are taking LOVENOX
®
before any surgery is scheduled and before any new drug is taken.
All patients should be carefully monitored by their doctor while taking LOVENOX
®
. Your doctor is likely to obtain blood tests that measure your
blood count and check for signs of hidden bleeding while you are on LOVENOX
®
.
You should call your doctor immediately if you notice any of the following: unusual bleeding or bleeding that lasts a long time, unusual
bruising, signs of thrombocytopenia (such as a rash or dark spots under the skin), tingling or numbness (especially in the lower limbs), and
muscular weakness.
The most common side effects from the use of LOVENOX
®
are mild pain, irritation, bruising, or redness of the skin at the site of injection.
Other common side effects include bleeding, anemia, diarrhea, nausea, ecchymosis, fever, edema, peripheral edema, dyspnea, confusion,
and injection site pain
Do not stop taking LOVENOX
®
without first talking to the doctor who prescribed it for you.
For specific questions about your health, you should always consult your doctor or a qualified healthcare professional who is responsible for
your care.
Please see accompanying full prescribing information for LOVENOX
®
, including boxed WARNING, for additional
important information.
© 2021 sanofi-aventis U.S. LLC. ALL RIGHTS RESERVED MAT-US-2104418-v1.0-05/2021